Recent therapeutic drug progress on neuroendocrine prostate cancer / 中华泌尿外科杂志
Chinese Journal of Urology
;
(12): 709-712, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-869735
ABSTRACT
Neuroendocrine prostate cancer(NEPC) is a prostate cancer subtype with a very high degree of malignancy and a special molecular phenotype.NEPC is not sensitive to endocrine therapy, and there are currently no specific drugs, so there is a lack of effective clinical treatment.New advances in NEPC therapeutic include chemical therapy, targeted drug therapy based on molecular phenotype and other non-targeted drug therapy. This article summarizes the current treatment methods, pharmaceutical, and clinical research results for NEPC, aiming to deepen clinicians' more comprehensive understanding of NEPC patients' treatment strategies.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Urology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS